Pharsight Corporation develops and markets software and provides consulting services that help pharmaceutical and biotechnology companies improve drug development decision making by reducing the costs and time of drug development and commercialization. Our products include proprietary software for clinical trial simulation and computer-aided trial design, the statistical analysis and mathematical modeling of data, the automation of scriptable pharmacokinetic data analysis, the storage, management, and regulatory reporting of derived data and models in data repositories, the validation of regulatory workflows, and the visualization of drug-disease simulations. Pharsight uses expertise in the sciences of pharmacology, drug and disease modeling, biostatistics and strategic decision-making. Our service offerings use this expertise to analyze and report trial results, to interpret and improve the design of scientific experiments and clinical trials, and to optimize clinical trial design and portfolio decisions. By integrating scientific, clinical, and business decision criteria into a dynamic model-based methodology, we help our customers to optimize the value of their drug development programs and portfolios from discovery to post-launch marketing. Our goal is to enable pharmaceutical and biotechnology companies to reduce the time, cost and risks of drug development activities and improve the value of approved medicines. Our products and services are designed to help our customers use a more rigorous scientific and statistical process to identify earlier drug candidates that will not be successful, to enhance the likelihood that the remaining candidates will successfully complete clinical trials, and to maximize marketing impact upon approval. This process is significant because clinical development time has remained lengthy and unpredictable while the productivity of molecule discovery research has accelerated dramatically in recent years.
Company profile
Ticker
PHST
Exchange
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Oracle • Lineage • ADT • Mobileye Global • Activision Blizzard • Gen Digital • Vmware • Adobe • Salesforce • BlackBerry Limited ...
SEC CIK
Corporate docs
IRS number
770401273
Latest filings (excl ownership)
EFFECT
Notice of effectiveness
4 Nov 08
15-12B
Securities registration termination
31 Oct 08
25-NSE
Exchange delisting
31 Oct 08
POS AM
Prospectus update (post-effective amendment)
31 Oct 08
S-8 POS
Registration of securities for employees (post-effective amendment)
31 Oct 08
S-8 POS
Registration of securities for employees (post-effective amendment)
31 Oct 08
S-8 POS
Registration of securities for employees (post-effective amendment)
31 Oct 08
S-8 POS
Registration of securities for employees (post-effective amendment)
31 Oct 08
S-8 POS
Registration of securities for employees (post-effective amendment)
31 Oct 08
S-8 POS
Registration of securities for employees (post-effective amendment)
31 Oct 08
Latest ownership filings
No filings